Ledger.Open graph →
SEC Form D · filed April 13, 2017

Urigen Pharmaceuticals, Inc

Offering
$15.0M
Sold
$500K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
North Brunswick, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Dan Vickery · North Brunswick, NJExec · DirectorCarlo L. Di Fonzo · North Brunswick, NJDirectorAbe L. Hahn · North Brunswick, NJDirectorC. L. Parsons · North Brunswick, NJDirectorPatrick Soon-Shiong · Cardiff, CADirectorJames Woody · Cardiff, CAExec · DirectorIvor Royston · Cardiff, CADirectorRichard Ghalie · Cardiff, CADirectorPauline Motts · EL PASO, TXDirectorJoe Schiff · EL PASO, TXDirectorPaul Arellano · EL PASO, TXDirectorLuis Gomez · EL PASO, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗